Innovent Biopharmaceutical Transformation

Long-Term Vision Developing core competiveness based on strategic vision, global talent and strong execution 2025 2030 Innovent 2021 • 6 commercialized products More products at late stage development Increased GMP manufacturing capacity Established Labs in the US . Expanded commercialized products in China • Multiple products approved in the global markets . Global commercial supply • More commercialized · products, including first-in-class blockbusters launched globally To be a premier global biopharmaceutical company

View entire presentation